Popular Articles

OncoGenex Pharmaceuticals To Webcast ASCO Reception On May 30, 2009
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company will hold a live webcast and conference call of presentations made at an OncoGenex hosted reception during the 2009 American Society of Clinical Oncology Annual Meeting (ASCO) on Saturday, May 30, 2009. The webcast will begin at 7:10 p.m. EDT.

Swine Flu: Health Departments Get Mixed Marks For Using Web To Communicate About Crisis, Study Finds
State and local health departments get mixed marks for efforts to convey information about the H1N1 virus to the public using their Web sites immediately after U.S. officials declared a public health emergency in April, according to a new RAND Corporation study.
News of the day
New Clinical Data For Tesetaxel, A Leading Oral Taxane, Show Anticancer Activity And Acceptable Safety In Ongoing Study
Genta Incorporated (OTCBB: GNTA.OB) announced preliminary results from its ongoing clinical study of tesetaxel, a leading oral taxane in the Company"s investigational drug portfolio. The new data show a favorable safety profile with a low incidence of serious adverse events, along with objective responses that have been observed at less than the maximally tolerated dose (MTD). The data are featured in a presentation today at the annual meeting of the American Society of Clinical Oncology (ASCO) in Orlando, FL.
Nutrition

Over Half Of People With Rheumatoid Arthritis Have Periodontitis

Over half (56%) of people with rheumatoid arthritis (RA) also have periodontitis (a chronic inflammatory disease of the gum and surrounding ligaments and bones that hold the teeth in place), displaying fewer teeth than healthy matched controls, high prevalence of oral sites presenting dental plaque and advanced attachment loss (the extent of periodontal support that has been destroyed around a tooth) (chi square p


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):